Diflunisal - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for diflunisal and what is the scope of patent protection?
Diflunisal
is the generic ingredient in two branded drugs marketed by Ani Pharms, Dastech Intl, Heritage Pharma, Purepac Pharm, Teva, Watson Labs, Zydus Pharms, and Merck, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.There are seven drug master file entries for diflunisal. Six suppliers are listed for this compound.
Summary for diflunisal
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 8 |
NDAs: | 10 |
Drug Master File Entries: | 7 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 120 |
Clinical Trials: | 6 |
Patent Applications: | 7,247 |
Drug Prices: | Drug price trends for diflunisal |
What excipients (inactive ingredients) are in diflunisal? | diflunisal excipients list |
DailyMed Link: | diflunisal at DailyMed |
Recent Clinical Trials for diflunisal
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Bristol-Myers Squibb | Phase 1 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Federal University of São Paulo | Phase 4 |
Pharmacology for diflunisal
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for diflunisal
Anatomical Therapeutic Chemical (ATC) Classes for diflunisal
US Patents and Regulatory Information for diflunisal
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | DIFLUNISAL | diflunisal | TABLET;ORAL | 074400-001 | Jul 17, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Heritage Pharma | DIFLUNISAL | diflunisal | TABLET;ORAL | 202845-002 | Aug 16, 2024 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Zydus Pharms | DIFLUNISAL | diflunisal | TABLET;ORAL | 203547-001 | Jun 16, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva | DIFLUNISAL | diflunisal | TABLET;ORAL | 073679-001 | Jul 31, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-002 | Apr 19, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Heritage Pharma | DIFLUNISAL | diflunisal | TABLET;ORAL | 202845-001 | Mar 8, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Dastech Intl | DIFLUNISAL | diflunisal | TABLET;ORAL | 073562-001 | Nov 27, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for diflunisal
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-001 | Apr 19, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-002 | Apr 19, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-002 | Apr 19, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-001 | Apr 19, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.